explore -WSS

explore

author：hotspot 2025-09-27 12:22:01 - browse：391

A gene-edited Yucatan minipig. -- health coverage from STAT — A gene-edited Yucatan minipig created by eGenesis. Courtesy Liz Linder/eGenesis

For three days in December, an ICU room at the Hospital of the University of Pennsylvania bore witness to the first-ever merging of two powerful new technologies poised to change the future of transplant medicine.

On a gurney, a brain-dead patient lay connected to a whirring Rube Goldberg-esque machine: a tangle of tubes and siphons on wheels. From a cannula on one end, blood from the patient entered, was pumped full of oxygen and other nutrients, then pushed into a cozy, temperature-controlled chamber containing a liver — one that until very recently had belonged to a CRISPR-edited pig — before being returned to the patient.

The experiment, designed to test whether a genetically engineered porcine liver kept alive in a box could support the circulatory system of a human, was a resounding success, the research team said Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Medicare Advantage proposed rates disappoint insurers

knowledge

WSS

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

A disappointing year of Humira biosimilars

Patients, doctors press FTC to beef up hospital merger scrutiny

Medicare threatens to cut off funding for HCA's Mission hospital

Private equity deals in Medicare Advantage declines

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

hotspot

explore

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

The dental labor crisis is a moment of opportunity

Walensky prepares to leave CDC — and Congress — behind

Private equity deals in Medicare Advantage declines

Medical records are filled with copy

'Revelatory' study finds a smoking impact that remains after quitting

Psychedelics group wrestles with new pharma identity

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Sports medicine is finally prioritizing gender equality

The unintended consequences of overturning Roe v. Wade

leisure time

Midwives could help bridge maternal health disparities in the U.S.

Biden report: The neurospychology of memory and aging

Medicare threatens to cut off funding for HCA's Mission hospital

Fed up with FDA, ALS advocates consider a take

The struggle to figure out which patients 'deserve' Wegovy

Medicare to pay more for cardiac rehab in hospital outpatient clinics

knowledge

hotspot

Wikipedia

hotspot